Donath, Marc Y.
Article History
First Online: 23 May 2014
Competing interests
: M.Y.D. is listed as the inventor on a patent (WO6709) filed in 2003 for the use of an interleukin-1 receptor antagonist for the treatment of, or prophylaxis against, type 2 diabetes.